Home
About Us
Overview
Mission and Vision
Board of Directors
Message from Chairperson
Message from MD
Sales & Marketing
Global Footprint
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutic Area
AgroVet & Pesticides
Herbal & Nutraceuticals
Facilities
Production
Quality Control
Quality Assurance
Product Development
Distribution Network
Investors
IPO
Annual Reports
Half Yearly Reports
Quarterly Reports
Price Sensitive Information
Director’s Reports
Shareholding Status
C G Compliance Status
Announcement
Dividend Distribution Policy
Dividend Compliance Reports
Unpaid/Unclaimed Dividend
Investor Relations Contact
News & Events
Company News
Medical News
Photo Gallery
Career
Available Jobs
Send us CV
Contact Us
Pharmacovigilance
Menu
Home
About Us
Overview
Mission and Vision
Board of Directors
Message from Chairperson
Message from MD
Sales & Marketing
Global Footprint
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutic Area
AgroVet & Pesticides
Herbal & Nutraceuticals
Facilities
Production
Quality Control
Quality Assurance
Product Development
Distribution Network
Investors
IPO
Annual Reports
Half Yearly Reports
Quarterly Reports
Price Sensitive Information
Director’s Reports
Shareholding Status
C G Compliance Status
Announcement
Dividend Distribution Policy
Dividend Compliance Reports
Unpaid/Unclaimed Dividend
Investor Relations Contact
News & Events
Company News
Medical News
Photo Gallery
Career
Available Jobs
Send us CV
Contact Us
Pharmacovigilance
Archives:
IPO
IPO
December-2018
January-2019
February-2019
March-2019
April-2019
May-2019
T Code DSE CSE MB
SILVA PHL AGGREGATED-841
RB Final Allocation
NRB Final Allocation
Posts navigation
← Previous
1
…
5
6
7
8
Next →